Took almost 10 months to dose 6 patients in Sheba and progress from P1b to P2.
We don't know how many patients will feature in each cohort at PACS. Surely with multiple trial sites and a far broader market opportunity, odds must be pretty good for H1 CY25 update. Despite not yet receiving ethics approval, the first two trial sites will be onboarding simultaneously.
Took almost 10 months to dose 6 patients in Sheba and progress...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.34 |
Change
-0.015(1.11%) |
Mkt cap ! $231.9M | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.36 | $1.31 | $132.3K | 98.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.34 | 10069 | 2 |
View Market Depth
| Last trade - 15.54pm 20/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |